Erck Stanley C
Insider CIK 1342826 · NVAX President and CEO, Director · MXCT Director · BCRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MXCT MAXCYTE, INC. | A Award deriv | 2026-06-17 | 2026-06-22 | 49,579 | — | $0 | 49,579 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2026-06-17 | 2026-06-22 | 30,421 | — | $0 | 428,749 | SEC↗ |
| MXCT MAXCYTE, INC. | P Buy | 2025-08-13 | 2025-08-13 | 100,000 | $1.37 | $137.0K | 398,328 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2025-06-18 | 2025-06-23 | 50,790 | — | $0 | 50,790 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2025-06-18 | 2025-06-23 | 29,210 | — | $0 | 298,328 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise deriv | 2024-11-01 | 2024-11-05 | 47,689 | — | $0 | 0 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2024-11-01 | 2024-11-05 | 47,689 | $3.72 | $177.4K | 269,118 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise | 2024-11-01 | 2024-11-05 | 47,689 | $0.04 | $1.9K | 316,807 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise deriv | 2024-10-02 | 2024-10-02 | 21,607 | — | $0 | 47,689 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2024-10-02 | 2024-10-02 | 21,607 | $3.71 | $80.2K | 269,118 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise | 2024-10-02 | 2024-10-02 | 21,607 | $0.04 | $864 | 290,725 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise deriv | 2024-10-01 | 2024-10-02 | 26,082 | — | $0 | 69,296 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise | 2024-10-01 | 2024-10-02 | 26,082 | $0.04 | $1.0K | 295,200 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2024-10-01 | 2024-10-02 | 26,082 | $3.78 | $98.6K | 269,118 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise deriv | 2024-09-04 | 2024-09-05 | 29,767 | — | $0 | 95,378 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2024-09-04 | 2024-09-05 | 29,767 | $3.97 | $118.2K | 269,118 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise | 2024-09-04 | 2024-09-05 | 29,767 | $0.04 | $1.2K | 298,885 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise deriv | 2024-09-03 | 2024-09-05 | 17,922 | — | $0 | 125,145 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2024-09-03 | 2024-09-05 | 17,922 | $4.10 | $73.5K | 269,118 | SEC↗ |
| MXCT MAXCYTE, INC. | M Exercise | 2024-09-03 | 2024-09-05 | 17,922 | $0.04 | $717 | 287,040 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2024-06-11 | 2024-06-13 | 40,701 | — | $0 | 40,701 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2024-06-11 | 2024-06-13 | 21,367 | — | $0 | 269,118 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2023-06-22 | 2023-06-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2022-12-14 | 2022-12-16 | 6,966 | — | $0 | 6,967 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2022-12-14 | 2022-12-16 | 2,320 | $17.23 | $40.0K | 36,492 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2022-12-14 | 2022-12-16 | 6,966 | — | $0 | 38,812 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2022-09-26 | 2022-09-28 | 6,546 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2022-09-26 | 2022-09-28 | 2,180 | $18.87 | $41.1K | 31,846 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2022-09-26 | 2022-09-28 | 6,546 | — | $0 | 34,026 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2022-06-29 | 2022-07-08 | 26,900 | — | $0 | 26,900 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-03-10 | 2022-03-14 | 41,474 | — | $0 | 41,474 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-03-10 | 2022-03-14 | 62,211 | — | $0 | 62,211 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-12-14 | 2021-12-16 | 6,967 | — | $0 | 13,933 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2021-12-14 | 2021-12-16 | 3,366 | $168.43 | $566.9K | 27,480 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-12-14 | 2021-12-16 | 6,967 | — | $0 | 30,846 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-04 | 2021-10-05 | 10,829 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-04 | 2021-10-05 | 32,000 | — | $0 | 36,499 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 4,700 | $176.48 | $829.5K | 45,132 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-04 | 2021-10-05 | 32,000 | $27.60 | $883.2K | 55,879 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 500 | $180.58 | $90.3K | 23,879 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 3,300 | $179.48 | $592.3K | 24,379 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 8,563 | $178.46 | $1.53M | 27,679 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 8,890 | $177.58 | $1.58M | 36,242 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-04 | 2021-10-05 | 10,829 | $27.00 | $292.4K | 66,708 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 3,600 | $175.61 | $632.2K | 49,832 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 3,100 | $174.56 | $541.1K | 53,432 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 5,038 | $173.45 | $873.8K | 56,532 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 3,746 | $172.36 | $645.7K | 61,570 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-04 | 2021-10-05 | 1,392 | $166.98 | $232.4K | 65,316 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-01 | 2021-10-05 | 14,000 | — | $0 | 68,499 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-01 | 2021-10-05 | 35,000 | — | $0 | 10,829 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 100 | $187.95 | $18.8K | 25,853 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 8 | $185.71 | $1.5K | 25,953 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 192 | $183.61 | $35.3K | 25,961 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 300 | $182.40 | $54.7K | 26,153 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 1,600 | $181.21 | $289.9K | 26,453 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 2,541 | $180.42 | $458.4K | 28,053 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 1,323 | $179.29 | $237.2K | 30,594 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 4,604 | $178.27 | $820.8K | 31,917 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 6,227 | $177.37 | $1.10M | 36,521 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 2,601 | $176.24 | $458.4K | 42,748 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 3,602 | $175.15 | $630.9K | 45,349 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 5,853 | $174.30 | $1.02M | 48,951 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 3,002 | $173.16 | $519.8K | 54,804 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 4,103 | $172.02 | $705.8K | 57,806 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 2,602 | $171.34 | $445.8K | 61,909 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 901 | $170.07 | $153.2K | 64,511 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 1,959 | $169.05 | $331.2K | 65,412 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 2,801 | $167.88 | $470.2K | 67,371 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 1,100 | $166.62 | $183.3K | 70,172 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 904 | $165.68 | $149.8K | 71,272 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 703 | $164.74 | $115.8K | 72,176 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-01 | 2021-10-05 | 35,000 | $27.00 | $945.0K | 72,879 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 1,502 | $189.47 | $284.6K | 24,351 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-01 | 2021-10-05 | 472 | $190.63 | $90.0K | 23,879 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-01 | 2021-10-05 | 14,000 | $27.60 | $386.4K | 37,879 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-09-26 | 2021-09-28 | 6,546 | — | $0 | 6,546 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2021-09-26 | 2021-09-28 | 3,162 | $248.16 | $784.7K | 23,879 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-09-26 | 2021-09-28 | 6,546 | — | $0 | 27,041 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2021-08-09 | 2021-08-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-07-02 | 2021-07-06 | 25,120 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-07-02 | 2021-07-06 | 27,439 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 628 | $220.80 | $138.7K | 21,170 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 2,994 | $216.92 | $649.5K | 44,221 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 7,423 | $218.77 | $1.62M | 26,829 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 5,190 | $215.74 | $1.12M | 47,215 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 4,466 | $214.76 | $959.1K | 52,405 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 2,355 | $213.38 | $502.5K | 56,871 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 7,616 | $212.29 | $1.62M | 59,226 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 4,242 | $211.21 | $896.0K | 66,842 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 1,970 | $210.23 | $414.2K | 71,084 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-07-02 | 2021-07-06 | 27,439 | $121.00 | $3.32M | 73,054 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-07-02 | 2021-07-06 | 25,120 | $36.60 | $919.4K | 45,615 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 5,031 | $219.76 | $1.11M | 21,798 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 9,969 | $217.84 | $2.17M | 34,252 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-02 | 2021-07-06 | 675 | $221.53 | $149.5K | 20,495 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-07-01 | 2021-07-06 | 17,560 | — | $0 | 27,439 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-07-01 | 2021-07-06 | 15,181 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-07-01 | 2021-07-06 | 19,879 | — | $0 | 25,120 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-01 | 2021-07-06 | 1,329 | $215.70 | $286.7K | 20,495 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-01 | 2021-07-06 | 6,984 | $214.97 | $1.50M | 21,824 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-01 | 2021-07-06 | 12,917 | $214.13 | $2.77M | 28,808 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-01 | 2021-07-06 | 12,703 | $213.07 | $2.71M | 41,725 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-01 | 2021-07-06 | 6,419 | $212.15 | $1.36M | 54,428 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-01 | 2021-07-06 | 4,117 | $211.07 | $869.0K | 60,847 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-01 | 2021-07-06 | 6,105 | $210.02 | $1.28M | 64,964 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-01 | 2021-07-06 | 2,046 | $209.20 | $428.0K | 71,069 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-07-01 | 2021-07-06 | 17,560 | $121.00 | $2.12M | 73,115 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-07-01 | 2021-07-06 | 19,879 | $36.60 | $727.6K | 55,555 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-07-01 | 2021-07-06 | 15,181 | $25.60 | $388.6K | 35,676 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-12-14 | 2020-12-16 | 20,900 | — | $0 | 20,900 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-12-14 | 2020-12-16 | 41,700 | — | $0 | 41,700 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2020-11-16 | 2020-11-18 | 42,499 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2020-11-16 | 2020-11-18 | 9,818 | — | $0 | 35,182 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-11-16 | 2020-11-18 | 4,909 | $93.56 | $459.3K | 20,495 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-11-16 | 2020-11-18 | 17,503 | $92.97 | $1.63M | 25,404 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-11-16 | 2020-11-18 | 4,598 | $90.61 | $416.6K | 42,907 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-11-16 | 2020-11-18 | 11,234 | $89.26 | $1.00M | 47,505 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-11-16 | 2020-11-18 | 8,306 | $88.36 | $733.9K | 58,739 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-11-16 | 2020-11-18 | 5,766 | $87.20 | $502.8K | 67,045 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2020-11-16 | 2020-11-18 | 9,818 | $25.60 | $251.3K | 72,811 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2020-11-16 | 2020-11-18 | 42,499 | $39.80 | $1.69M | 62,993 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-10-01 | 2020-10-01 | 2 | $108.57 | $217 | 20,494 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 1,500 | $109.54 | $164.3K | 25,572 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 700 | $114.20 | $79.9K | 21,496 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 800 | $112.65 | $90.1K | 22,196 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 900 | $111.41 | $100.3K | 22,996 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 1,676 | $110.54 | $185.3K | 23,896 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 800 | $114.73 | $91.8K | 20,696 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 5,138 | $108.56 | $557.8K | 27,072 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 517 | $107.56 | $55.6K | 32,210 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 100 | $115.65 | $11.6K | 20,496 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-30 | 2020-10-01 | 100 | $115.43 | $11.5K | 20,596 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-29 | 2020-09-30 | 1,112 | $108.40 | $120.5K | 33,727 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-29 | 2020-09-30 | 1,000 | $107.25 | $107.3K | 34,839 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-29 | 2020-09-30 | 1,000 | $106.22 | $106.2K | 35,839 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-29 | 2020-09-30 | 1,000 | $109.25 | $109.3K | 32,727 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2020-09-28 | 2020-09-30 | 25,000 | — | $0 | 75,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2020-09-28 | 2020-09-30 | 25,000 | — | $0 | 75,000 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 551 | $117.07 | $64.6K | 36,839 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 951 | $116.08 | $110.3K | 37,390 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 1,003 | $115.23 | $115.5K | 38,341 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 401 | $113.81 | $45.6K | 39,343 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 727 | $113.02 | $82.1K | 39,744 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 216 | $111.92 | $24.1K | 40,471 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 2,343 | $110.97 | $260.0K | 40,687 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 8,133 | $109.98 | $894.4K | 43,030 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 6,661 | $109.07 | $726.6K | 51,163 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 3,739 | $108.20 | $404.6K | 57,824 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2020-09-28 | 2020-09-30 | 276 | $107.22 | $29.6K | 61,563 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2020-09-28 | 2020-09-30 | 11,429 | $111.18 | $1.27M | 61,839 | SEC↗ |
| NVAX NOVAVAX INC | D To issuer | 2020-09-28 | 2020-09-30 | 1,338 | $111.18 | $148.8K | 73,268 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2020-09-28 | 2020-09-30 | 25,000 | $5.95 | $148.8K | 74,606 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2020-09-28 | 2020-09-30 | 25,000 | $5.95 | $148.8K | 49,606 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2020-09-26 | 2020-09-29 | 6,546 | — | $0 | 13,092 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2020-09-26 | 2020-09-29 | 6,546 | — | $0 | 27,040 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2020-09-26 | 2020-09-29 | 2,434 | $113.56 | $276.4K | 24,606 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-08-24 | 2020-08-26 | 400,000 | — | $0 | 400,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-06-25 | 2020-06-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2020-03-08 | 2020-03-10 | 6,072 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2020-03-08 | 2020-03-10 | 6,072 | — | $0 | 22,486 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2020-03-08 | 2020-03-10 | 1,992 | $12.48 | $24.9K | 20,494 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2019-09-26 | 2020-06-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2019-09-26 | 2019-09-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2019-09-26 | 2019-09-30 | 19,638 | — | $0 | 100,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2019-09-26 | 2019-09-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2019-03-08 | 2019-03-12 | 607,248 | — | $0 | 607,248 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2018-12-13 | 2018-12-14 | 1,970,000 | — | $0 | 1,970,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-28 | 2018-11-30 | 8,333 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-28 | 2018-11-30 | 8,333 | $1.49 | $12.4K | 48,333 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-06-20 | 2018-06-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2018-05-14 | 2018-05-15 | 100,000 | $1.65 | $165.0K | 328,279 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2017-12-15 | 2017-12-19 | 1,650,000 | — | $0 | 1,650,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2017-11-09 | 2017-11-13 | 100,000 | $1.13 | $113.0K | 228,279 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-05-24 | 2017-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2017-05-11 | 2017-05-11 | 50,000 | $0.84 | $42.0K | 128,279 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2016-11-14 | 2016-11-16 | 550,000 | — | $0 | 550,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2016-11-14 | 2016-11-16 | 550,000 | — | $0 | 550,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2016-03-31 | 2016-04-01 | 201,991 | — | $0 | 500,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2016-03-31 | 2016-04-01 | 201,991 | $1.28 | $258.5K | 305,048 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2016-03-31 | 2016-04-01 | 226,769 | $5.18 | $1.17M | 78,279 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2016-03-30 | 2016-04-01 | 198,009 | — | $0 | 701,991 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2016-03-30 | 2016-04-01 | 198,009 | $5.19 | $1.03M | 103,057 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2016-03-30 | 2016-04-01 | 198,009 | $1.28 | $253.5K | 301,066 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2016-03-15 | 2016-03-17 | 900,000 | — | $0 | 900,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2016-01-31 | 2016-02-01 | 2,072 | $4.38 | $9.1K | 103,057 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2015-07-31 | 2015-08-04 | 3,207 | $2.28 | $7.3K | 100,985 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-05-20 | 2015-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2015-03-05 | 2015-03-09 | 900,000 | — | $0 | 900,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2015-01-31 | 2015-02-03 | 6,122 | $2.28 | $14.0K | 97,778 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-07-31 | 2014-08-04 | 6,788 | $2.28 | $15.5K | 91,656 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-05-02 | 2014-05-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-03-25 | 2014-03-25 | 10,000 | $4.27 | $42.7K | 84,868 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-03-25 | 2014-03-25 | 10,000 | $4.27 | $42.7K | 84,868 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2014-03-06 | 2014-03-07 | 900,000 | — | $0 | 3,720,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-01-31 | 2014-02-04 | 11,868 | $2.29 | $27.2K | 74,868 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-05-31 | 2013-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2013-03-02 | 2013-03-06 | 900,000 | $1.83 | $1.65M | 2,970,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2012-05-23 | 2012-05-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2012-03-01 | 2012-03-09 | 900,000 | $1.28 | $1.15M | 2,070,000 | SEC↗ |